跳至主要内容
临床试验/CTRI/2022/04/041831
CTRI/2022/04/041831尚未招募2 期

Comparative evaluation of Dalk-i-Muâ??tadil with Roghan-i-Qust versus Roghan-i-Sosan in Distal Symmetric Polyneuropathy (DSPN) of Diabetic originâ??A randomised clinical trial - DNM

ational Institute of Unani Medicine Bengaluru0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Documented Diagnosed cases of Type 1 or 2 diabetes
  • Patients of either sex
  • Patients older than 20 years and less than 60 years of age
  • Stable glycemic control for 3 months i.e. HbA1c < 8%.
  • DSPN defined by:
  • Bilateral reduced or absent reflexes at the ankles
  • Bilateral impaired vibration, pinprick, fine touch or temperature perception in the distal lower extremities.
  • Persistent distal burning or dull pain in the feet
  • Persistent proximal aching pain in the legs
  • Paroxysmal electric, shooting, stabbing pain
  • Dysasthesias

排除标准

  • Patient less than 20 years and more than 60 years
  • Physiological state as pregnancy and lactation.
  • Patients having abnormal blood urea, serum creatinine, SGOT, SGPT.
  • Other causes of neuropathy or lower extremity pain
  • Uncontrolled hypertension at screen (sitting systolic >160 mmHg and/or sitting diastolic >90 mmHg
  • Currently participating in another clinical study in which the subject is, or will be exposed to an investigational or non-investigational drug or device.
  • Pathological state such as cardiovascular diseases, renal diseases, hepatic diseases, peripheral arterial diseases.
  • Unwillingness or inability to comply the requirements of the protocol

研究者

发起方
ational Institute of Unani Medicine Bengaluru

相似试验